Original- und Übersichtsarbeiten im Jahr 2008

Raum E, Lietzau S, von Baum H, Marre R, Brenner H.
Changes of E. coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany.
Clinical Microbiology and Infection 2008; 14: 41-48.

Brenner H, Hakulinen T.
Period versus cohort modeling of up-to-date cancer survival.
International Journal of Cancer 2008; 122: 898-904.

Brenner H, Gondos A, Pulte D.
Recent major improvement in long-term survival of younger patients with multiple myeloma.
Blood 2008; 111: 2521-2526.

Pulte D, Gondos A, Brenner H.
Ongoing improvement in outcomes for patients diagnosed with non-Hodgkin lymphoma
from the 1990s to the early 21st century.
Archives of Internal Medicine 2008; 168: 469-476.

Brenner H, Gondos A, Pulte D.
Ongoing improvement in long-term survival of patients with Hodgkin’s disease at all ages and recent catch-up of older patients.
Blood 2008; 111: 2977-2983.

Tan, X-L, Nieters A, Kropp S, Hoffmeister M, Brenner H, Chang-Claude J.
The association of cyclin D1 G870A and E-cadherin C–160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.
International Journal of Cancer 2008; 122: 2573-2580.

Pulte D, Gondos A, Brenner H.
Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century.
Haematologica – The Hematology Journal 2008; 93: 594-600.

Brenner H.
Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods. In: Classen M, Maar C (Eds.) Europe against colorectal cancer. Outlining a pan-European colon cancer screening program.
Zeitschrift für Gastroenterologie 2008; 46: S20-S22.

Raum E, Lietzau S, Stegmaier C, Brenner H., Rothenbacher D.
For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
Pharmacoepidemiology and Drug Safety 2008; 17: 485-494.

Tenesa A, Farrington SM, Prendergast JGD, Porteous ME, Walker M, Haq N, Barnetson RA, Theodoratou E, Cetnarskyj R, Cartwright N, Wilson R, Semple C, Clarke AJ, Reid FJL, Smith LA, Kavoussanakis K, Kossler T, Pharoah PDP, Buch S, Schafmayer C, Tepel J, Schreiber S, Völzke H, Schmidt CO, Hampe J, Wilkening S, Canzian F, Chang-Claude J, Hoffmeister M, Brenner H, Capella G, Moreno V, Deary IJ, Starr JM, Tomlinson IPM, Webb E, Houlston RS, Rennert G, Ballinger D, Rozek L, Gruber SB, Matsuda K, Kidokoro T, Nakamura Y, Zanke BW, Greenwood CMT, Rangrej J, Kustra R, Montpetit A, Hudson TJ, Gallinger S, Campbell H, DunlopMG.
Genome-wide association scan identifies three colorectal cancer susceptibility loci.
Nature Genetics 2008; 40: 631-637.

Breitling LP, Twardella D, Brenner H.
High effectiveness of short treatment with bupropion for smoking cessation in general care.
Thorax 2008; 63: 476-477.

Brenner H, Gondos A, Pulte D.
Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century.
Blood 2008; 111: 4916-4921.

von Eynatten M, Hamann A, Twardella D, Nawroth P, Brenner H, Rothenbacher D.
Atherogenic dyslipidemia but not total and high molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease.
European Heart Journal 2008; 29: 1307-1315.

Riera-Guardia N, Rothenbacher D.
The effect of thiazolidinediones on adiponectin serum level: a meta-analysis.
Diabetes, Obesity and Metabolism 2008; 10: 367-375.

Zhang Q-L, Rothenbacher D.
Prevalence of chronic kidney disease in population-based studies: Systematic review.
BMC Public Health 2008; 8: 117.

Twardella D, Brenner H.
Implications of nonresponse patterns in the analysis of smoking cessation trials.
Nicotine & Tobacco Research 2008; 10: 891-896.

Gondos A, Bray F, Brewster DH, Coebergh JWW, Hakulinen T, Janssen-Heijnen MLG,.
Kurtinaitis J, Brenner H and the EUNICE Survival Working Group.
Recent trends in cancer survival across Europe between 2000 and 2004: a model-based
period analysis from 12 cancer registries.
European Journal of Cancer 2008; 44: 1463-1475.

Weck MN, Brenner H.
Association of Helicobacter pylori infection with chronic atrophic gastritis: Meta-analyses according to type of disease definition.
International Journal of Cancer 2008; 123: 874-881.

Hoffmeister M, Haug H, Brenner H.
Welche Voraussetzungen sind für ein Screening notwendig?
Der Internist 2008; 49: 655-659.

Haug U, Hundt S, Brenner H.
Sensitivity and specificity of faecal tumour M 2 pyruvate kinase for detection of colorectal adenomas in a large screening study.
British Journal of Cancer 2008; 99: 133-135.

Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U, Stegmaier C, Jacobs IJ, Brenner H.
Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study.
PloS ONE 2008; 3: e2656.

Brenner H, Hoffmeister M, Haug U.
Should colorectal cancer screening start at the same age in European countries? Contributions from descriptive epidemiology.
British Journal of Cancer 2008; 99: 532-535.

Gao L, Nieters A, Brenner H.
Meta-analysis: Tumor invasion related genetic polymorphisms and gastric cancer susceptibility.
Alimentary Pharmacology Therapeutics 2008; 28: 565-573.

Funke S, Brenner H, Chang-Claude J.
Pharmacogenetics in colorectal cancer: a systematic review.
Pharmacogenomics 2008; 9: 1079-109.

Brenner H, Hoffmeister M, Haug U.
Family history and age at initiation of colorectal cancer screening.
American Journal of Gastroenterology 2008; 103: 2326-2331.

Soerjomataram I, Pukkala E, Brenner H, Coebergh JWW.
On the avoidability of breast cancer in industrialized societies: Older mean age at first birth as an indicator of excess breast cancer risk.
Breast Cancer Research and Treatment 2008; 111: 297-302.

Vossen CY, Hoffmann MM, Hahmann H, Wüsten B, Rothenbacher D, Brenner H.
Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week in-patient rehabilitation program.
Clinical Pharmacology and Therapeutics 2008; 84: 222-227.

Pulte, D, Gondos A, Brenner H.
Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Journal of the National Cancer Institute 2008; 100: 1301-1309.

Müller H, Haug U, Rothenbacher D, Stegmaier C, Brenner H.
Evaluation of serum and urine MRP-14 as marker for early detection of prostate cancer.
Journal of Urology 2008; 180: 1309-1313.

Brenner H., Gondos A, Pulte D.
Recent trends in long-term survival of patients with chronic myelocytic leukemia: disclosing the impact of advances in therapy on the population level.
Haematologica 2008; 93: 1544-1549.

Rachet B, Woods LM, Mitry E, Riga M, Cooper N, Quinn MJ, Steward J, Brenner H, Estève J, Sullivan R, Coleman MP.
Cancer survival in England and Wales at the end of the 20th century.
British Journal of Cancer 2008; 99 Suppl.1: S2-10.

Arndt V, Stegmaier C, Ziegler H, Brenner H.
Quality of life over five years in women with breast cancer after breast-conserving therapy versus mastectomy - a population based study.
Journal of Cancer Research and Clinical Oncology 2008; 134: 1311-1318.

Haug U, Wente MN, Seiler CM, Jesnowski R, Brenner H.
Stool testing for early detection of pancreatic cancer: rationale and current evidence.
Expert Review of Molecular Diagnostics 2008; 8: 753-759.

COGENT Study, Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, Chandler I, Vijayakrishnan J, Sullivan K, Prenegar S; Colorectal Cancer Association Study Consortium, Carvajal-Carmona L, Howarth K, Jaeger E, Spain SL, Walther A, Barclay E, Martin L, Gorman M, Domingo E, Teixeira AS; CoRGI Consortium, Kerr D, Cazier JB, Niittymäki I, Tuupanen S, Karhu A, Aaltonen LA, Tomlinson IP, Farrington SM, Tenesa A, Prendergast JG, Barnetson RA, Cetnarskyj R, Porteous ME, Pharoah PD, Koessler T, Hampe J, Buch S, Schafmayer C, Tepel J, Schreiber S, Völzke H, Chang-Claude J, Hoffmeister M, Brenner H, Zanke BW, Montpetit A, Hudson TJ, Gallinger S; International Colorectal Cancer Genetic Association Consortium, Campbell H, Dunlop MG.
Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer.
Nature Genetics 2008; 40: 1426-1435.